Edgewise Therapeutics Cash from Investing (TTM) Analysis

Edgewise Therapeutics Inc (EWTX)

19.92 +0.63 (+3.27%) USD | NASDAQ | May 03, 14:04

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	102.89M
September 30, 2023	0.307M
June 30, 2023	-49.43M
March 31, 2023	-52.92M
December 31, 2022	-70.58M
September 30, 2022	19.14M
June 30, 2022	13.85M

Date	Value
March 31, 2022	-146.07M
December 31, 2021	-242.23M
September 30, 2021	-280.53M
June 30, 2021	-248.92M
March 31, 2021	-89.14M
December 31, 2020	-24.38M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-280.53M

Minimum

Sep 2021

102.89M

Maximum

Dec 2023

-82.16M

Average

-52.92M

Median

Mar 2023

Cash from Investing (TTM) Benchmarks